Comprehensive and Understanding Care

More than 5 million Americans have Alzheimer's disease or related disorders that lead to a loss of mental function. If you or a loved one has Alzheimer's disease or another form of dementia, our team at NewYork-Presbyterian Hospital understands the toll these diseases can take on your quality of life and the lives of your family members. We have special expertise in evaluating and treating Alzheimer's and related disorders, offering.

  • A Team Approach: We provide compassionate and sensitive care from a multidisciplinary team which includes neurologists, neurosurgeons, psychiatrists, neuropsychologists, nurses, social workers, and genetic counselors.
  • A Comprehensive and Accurate Assessment: Our facilities have a wide spectrum of exceptional diagnostic services. These include neuro-imaging services, such as positron emission tomography (PET), single photon computed tomography (SPECT), magnetic resonance imaging (MRI), and computed tomography (CT) scanning, as well as cerebrospinal fluid and blood testing, neuropathological assessments, electroencephalography, and neuropsychological testing.
  • Genetic Testing: Our doctors have co-authored guidelines for the use of genetic testing in families with Alzheimer's disease. Genetic testing is available for members of families with Alzheimer's disease.
  • Personalized Treatment: Once we identify the cause of dementia, we determine the best course of treatment. We work with you and your family to address all facets of your condition, including neurologic, cognitive, and psychiatric symptoms.
  • Prevention Approaches: We address modifiable risk factors for Alzheimer’s disease, such as diet and exercise, which may in turn influence the rate of progression of or delay the onset of cognitive complaints.
  • Clinical Trials: We are conducting clinical studies and laboratory research to develop new treatments for mild cognitive impairment, Alzheimer's disease, and other forms of dementia, including frontotemporal dementia, progressive supranuclear palsy, and dementia with Lewy bodies. You or your loved one may have the opportunity to participate in a clinical trial.
  • Research Studies: We are studying the molecular and genetic basis of Alzheimer's disease and other forms of dementia, determining risk factors, and devising new neuropsychological tests and imaging techniques for diagnosis and monitoring.
  • Exceptional Research Facilities: Alzheimer's disease research is conducted at both of our campuses. At NewYork-Presbyterian Hospital/Columbia University Medical Center, our clinicians and scientists are making inroads at the Gertrude H. Sergievsky Center, the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, the New York State Psychiatric Institute, and the Alzheimer's Disease Research Center at Columbia University (one of 29 specialized centers around the country sponsored by the National Institute on Aging). At NewYork-Presbyterian Hospital/Weill Cornell Medical Center, research is conducted at the Helen and Robert Appel Alzheimer’s Disease Research Institute, the Clinical Translational Science Center, and the Citigroup Biomedical Imaging Center.